Equity Overview
Price & Market Data
Price: $1.59
Daily Change: +$0.04 / 2.52%
Range: $1.36 - $1.60
Market Cap: $34,445,444
Volume: 50,071
Performance Metrics
1 Week: 1.27%
1 Month: %
3 Months: -45.55%
6 Months: -46.82%
1 Year: -61.75%
YTD: -62.85%
Company Details
Employees: 4
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. OS Therapies Incorporated was incorporated in 2018 and is based in Rockville, Maryland.